Biomarkers or biotargets? Using competition to lure cancer cells into evolutionary traps.
Evolution, medicine, and public health(2023)
摘要
Evolution of functional biomarkers amplify the limitations of using total biomarker levels as a measure of tumor size when designing therapeutic protocols. Evolutionarily enlightened therapeutic strategies may be highly effective, assuming a targeted therapy against the biomarker is available.
更多查看译文
关键词
cancer cells,biomarkers,biotargets
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要